Analyst Coverage and Vara Consensus

Sanofi share is covered by sell-side analysts publishing regular research notes and estimates.
Analyst Coverage
CompanyName
Alpha Value
Abhishek Raval
Banco Sabadel
Rafael Bonardell
Bank of America
Graham Parry
Barclays  
Emily Field
Berenberg
Luisa Hector
Bernstein Société Générale
Florent Cespedes
BNP Paribas Exane
Peter Verdult
CIC
Arnaud Cadart
Deutsche Bank
Emmanuel Papadakis
Goldman Sachs
James Quigley
Guggenheim Securities
Seamus Fernandez
HSBC
Rajesh Kumar
Intesa Sanpaolo
Bruno Permutti
Jefferies
Ben Jackson
JP Morgan
Richard Vosser
Leerink Partners
David Risinger
Kepler Cheuvreux
David Evans
Morgan Stanley
Sarita Kapila
Morningstar
Jay Lee
Redburn Atlantic
Simon Baker
Santander
Jaime Escribano
Stifel
Eric le Berrigaud
TD Cowen    
Steve Scala
UBS
UBS Pharma Team

Vara Consensus

By clicking on the "I understand and I accept" link below, your browser will be transferred to an internet site where the content is posted, maintained and owned by Vara Research GmbH, containing Analysts’ Consensus Estimates. When linking to a third-party site, please be advised that you do so at your own risk. In no event shall Sanofi be responsible for your use of a linked site or its content.

Any information received through this link to the Vara Research GmbH internet site is not part of this Sanofi internet site and does not represent opinions, forecasts or predictions of Sanofi or its management. Furthermore, Sanofi provides no assurance with regard to the accuracy or correctness of the Analysts' Consensus Estimate.

Sanofi has no control over the content, quality, nature or reliability of any such third party internet sites, and shall have no liability whatsoever in respect of the information provided on this linked internet site or in the Analysts’ Consensus Estimates.

The link to the Vara Research GmbH internet site is provided as a courtesy and for convenience and informational purposes only. The information received through this link is not intended to imply any endorsement of Sanofi or provide any investment advice. Moreover, investors are warned that reliance on the Analysts' Consensus Estimates as part of their investment decision could results in a loss, especially if Sanofi fails to meet the Analysts’ Consensus Estimate.